Gamma-synuclein As a Marker of Retinal Ganglion Cells

Overview

Journal Mol Vis

Specialties Cell Biology
Molecular Biology
Ophthalmology

Date 2008 Aug 30

PMID 18728752

Citations 62

Authors

Irina Surgucheva

Alejandra D Weisman

Jeffrey L Goldberg

Alexander Shnyra

Andrei Surguchov

Affiliations

Soon will be listed here.

Abstract

Purpose: Previous studies have described gamma-synuclein as a protein highly expressed in retinal ganglion cells (RGCs), and a loss of RGCs correlates with a downregulation of gamma-synuclein gene expression in glaucoma. Here we asked whether gamma-synuclein expression in the retina can be considered a specific marker of RGCs.

Methods: gamma-Synuclein expression was examined with immunohistochemistry in retinal sections from normal and glaucomatous human eyes. Primary cultures of RGCs from Sprague-Dawley rats purified by sequential immunopanning using a monoclonal antibody to Thy1-1, cultures of A7 immortalized optic nerve astrocytes from newborn rats, and the immortalized RGC-5 cell line were studied using immunofluorescence and quantitative RT-PCR.

Results: gamma-Synuclein was highly expressed in RGCs in the human retina and was localized in cytoplasm adjacent to the RGC nuclear marker, Brn-3a. Axons of RGCs were immunopositive for gamma-synuclein in the nerve fiber layer (NFL), the lamina cribrosa and the retrobulbar optic nerve. In the optic nerve of glaucoma patients, axon swellings were likewise immunopositive, whereas in the retina of patients with retinoblastoma, NFL staining appeared reduced. In primary rat RGCs and in immortalized RGC-5 cultures, gamma-synuclein was localized predominantly in the perinuclear area and in cell processes. Among rat retinal cells in culture, all Brn-3a positive cells were stained with a gamma-synuclein antibody; rare gamma-synuclein-positive cells were not stained by the Brn-3a antibody.

Conclusions: gamma-Synuclein is selectively and abundantly expressed in human RGCs in vivo, primary rat RGCs in vitro, and immortalized RGC-5 cells. In pathology, gamma-synuclein abundance may vary between RGC somas and axons. Coincident Brn-3a and gamma-synuclein expression suggests that strong gamma-synuclein expression can be considered a marker of RGCs. Future translational approaches might include using a gamma-synuclein promoter for the specific delivery of siRNA or therapeutic proteins to RGCs.

Citing Articles

Gene therapy for glaucoma: Targeting key mechanisms.

Henderson J, OCallaghan J, Campbell M Vision Res. 2024; 225:108502.

PMID: 39423611 PMC: 11579448. DOI: 10.1016/j.visres.2024.108502.

Retinal ganglion cell type-specific expression of synuclein family members revealed by scRNA-sequencing.

Yang Q, Liu L, He F, Zhao W, Chen Z, Wu X Int J Med Sci. 2024; 21(8):1472-1490.

PMID: 38903914 PMC: 11186421. DOI: 10.7150/ijms.95598.

Establishing Functional Retina in a Dish: Progress and Promises of Induced Pluripotent Stem Cell-Based Retinal Neuron Differentiation.

Wong N, Yip S, Huang C Int J Mol Sci. 2023; 24(17).

PMID: 37686457 PMC: 10487913. DOI: 10.3390/ijms241713652.

Differential Responses of Retinal Neurons and Glia Revealed via Proteomic Analysis on Primary and Secondary Retinal Ganglion Cell Degeneration.

Kwong J, Caprioli J, Lee J, Song Y, Yu F, Bian J Int J Mol Sci. 2023; 24(15).

PMID: 37569482 PMC: 10418669. DOI: 10.3390/ijms241512109.

Intravitreal Injection of AAV for the Transduction of Mouse Retinal Ganglion Cells.

Nieuwenhuis B, Osborne A Methods Mol Biol. 2023; 2708:155-174.

PMID: 37558970 DOI: 10.1007/978-1-0716-3409-7_17.

References

Surgucheva I, Surguchov A . Gamma-synuclein: cell-type-specific promoter activity and binding to transcription factors. J Mol Neurosci. 2008; 35(3):267-71. DOI: 10.1007/s12031-008-9074-6. View

Quigley H, Addicks E . Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol. 1981; 99(1):137-43. DOI: 10.1001/archopht.1981.03930010139020. View

Doi M, Uji Y, Yamamura H . Morphological classification of retinal ganglion cells in mice. J Comp Neurol. 1995; 356(3):368-86. DOI: 10.1002/cne.903560305. View

Martinez-Navarrete G, Martin-Nieto J, Esteve-Rudd J, Angulo A, Cuenca N . Alpha synuclein gene expression profile in the retina of vertebrates. Mol Vis. 2007; 13:949-61. PMC: 3380420. View

Badea T, Nathans J . Quantitative analysis of neuronal morphologies in the mouse retina visualized by using a genetically directed reporter. J Comp Neurol. 2004; 480(4):331-51. DOI: 10.1002/cne.20304. View

Jensen P, Nielsen M, Jakes R, Dotti C, Goedert M . Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem. 1998; 273(41):26292-4. DOI: 10.1074/jbc.273.41.26292. View

Soto I, Oglesby E, Buckingham B, Son J, Roberson E, Steele M . Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci. 2008; 28(2):548-61. PMC: 6670511. DOI: 10.1523/JNEUROSCI.3714-07.2008. View

Aoun P, Simpkins J, Agarwal N . Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Invest Ophthalmol Vis Sci. 2003; 44(7):2999-3004. DOI: 10.1167/iovs.02-1060. View

Surgucheva I, McMahan B, Ahmed F, Tomarev S, Wax M, Surguchov A . Synucleins in glaucoma: implication of gamma-synuclein in glaucomatous alterations in the optic nerve. J Neurosci Res. 2002; 68(1):97-106. DOI: 10.1002/jnr.10198. View

10.

Gan L, Wang S, Huang Z, Klein W . POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification. Dev Biol. 1999; 210(2):469-80. DOI: 10.1006/dbio.1999.9280. View

11.

Surgucheva I, Sivak J, Fini M, Palazzo R, Surguchov A . Effect of gamma-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells. Arch Biochem Biophys. 2003; 410(1):167-76. DOI: 10.1016/s0003-9861(02)00664-1. View

12.

Meyer-Franke A, Kaplan M, Pfrieger F, Barres B . Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron. 1995; 15(4):805-19. DOI: 10.1016/0896-6273(95)90172-8. View

13.

Buckingham B, Inman D, Lambert W, Oglesby E, Calkins D, Steele M . Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci. 2008; 28(11):2735-44. PMC: 6670674. DOI: 10.1523/JNEUROSCI.4443-07.2008. View

14.

Quigley H . Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol. 1995; 23(2):85-91. DOI: 10.1111/j.1442-9071.1995.tb00135.x. View

15.

Huang W, Fileta J, Guo Y, Grosskreutz C . Downregulation of Thy1 in retinal ganglion cells in experimental glaucoma. Curr Eye Res. 2006; 31(3):265-71. DOI: 10.1080/02713680500545671. View

16.

Clayton D, George J . Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res. 1999; 58(1):120-9. View

17.

Quigley H . Number of people with glaucoma worldwide. Br J Ophthalmol. 1996; 80(5):389-93. PMC: 505485. DOI: 10.1136/bjo.80.5.389. View

18.

Wang J, Kunzevitzky N, Dugas J, Cameron M, Barres B, Goldberg J . Disease gene candidates revealed by expression profiling of retinal ganglion cell development. J Neurosci. 2007; 27(32):8593-603. PMC: 2885852. DOI: 10.1523/JNEUROSCI.4488-06.2007. View

19.

Quigley H . Glaucoma: macrocosm to microcosm the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2005; 46(8):2662-70. DOI: 10.1167/iovs.04-1070. View

20.

Chintala S, Zhang X, Austin J, Fini M . Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem. 2002; 277(49):47461-8. DOI: 10.1074/jbc.M204824200. View